Literature DB >> 16455686

Bidirectional modulation of GABAergic transmission by cholecystokinin in hippocampal dentate gyrus granule cells of juvenile rats.

Pan-Yue Deng1, Saobo Lei.   

Abstract

Cholecystokinin (CCK) interacts with two types of G protein-coupled receptors in the brain: CCK-A and CCK-B receptors. Both CCK and CCK-B receptors are widely distributed in the hippocampal formation, but the functions of CCK there have been poorly understood. In the present study, we initially examined the effects of CCK on GABA(A) receptor-mediated synaptic transmission in the hippocampal formation and then explored the underlying cellular mechanisms by focusing on the dentate gyrus region, where the highest levels of CCK-binding sites have been detected. Our results indicate that activation of CCK-B receptors initially and transiently increased spontaneous IPSC (sIPSC) frequency, followed by a persistent reduction. The effects of CCK were more evident in juvenile rats, suggesting that they are developmentally regulated. Cholecystokinin failed to modulate the miniature IPSCs recorded in the presence of TTX and the amplitude of the evoked IPSCs, but produced a transient increase followed by a reduction in action potential firing frequency recorded from GABAergic interneurons, suggesting that CCK acts by modulating the excitability of the interneurons to regulate GABA release. Cholecystokinin reduced the amplitude of the after-hyperpolarization of the action potentials, and application of paxilline or charybdotoxin considerably reduced CCK-mediated modulation of sIPSC frequency, suggesting that the effects of CCK are related to the inhibition of Ca(2+)-activated K(+) currents (I(K(Ca))). The effects of CCK were independent of the functions of phospholipase C, intracellular Ca(2+) release, protein kinase C or phospholipase A(2), suggesting a direct coupling between the G proteins of CCK-B receptors and I(K(Ca)). Our results provide a novel mechanism underlying CCK-mediated modulation of GABA release.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455686      PMCID: PMC1779673          DOI: 10.1113/jphysiol.2005.104463

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  71 in total

1.  Modulation of M-current by intracellular Ca2+.

Authors:  N V Marrion; R S Zucker; S J Marsh; P R Adams
Journal:  Neuron       Date:  1991-04       Impact factor: 17.173

2.  Cells of origin of entorhinal cortical afferents to the hippocampus and fascia dentata of the rat.

Authors:  O Steward; S A Scoville
Journal:  J Comp Neurol       Date:  1976-10-01       Impact factor: 3.215

3.  Cholecystokinin octapeptide-like immunoreactivity: histochemical localization in rat brain.

Authors:  R B Innis; F M Corrêa; G R Uhl; B Schneider; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

4.  Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog.

Authors:  J F Rehfeld
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

5.  Cholecystokinin in hippocampal pathways.

Authors:  R S Greenwood; S E Godar; T A Reaves; J N Hayward
Journal:  J Comp Neurol       Date:  1981-12-10       Impact factor: 3.215

6.  SK&F 96365, a novel inhibitor of receptor-mediated calcium entry.

Authors:  J E Merritt; W P Armstrong; C D Benham; T J Hallam; R Jacob; A Jaxa-Chamiec; B K Leigh; S A McCarthy; K E Moores; T J Rink
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

7.  Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.

Authors:  A Nishida; K Miyata; R Tsutsumi; H Yuki; S Akuzawa; A Kobayashi; T Kamato; H Ito; M Yamano; Y Katuyama
Journal:  J Pharmacol Exp Ther       Date:  1994-05       Impact factor: 4.030

8.  Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: a study by high pressure liquid chromatography.

Authors:  M Deschodt-Lanckman; N D Bui; M Noyer; J Christophe
Journal:  Regul Pept       Date:  1981-04

9.  The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay.

Authors:  M C Beinfeld; D K Meyer; R L Eskay; R T Jensen; M J Brownstein
Journal:  Brain Res       Date:  1981-05-11       Impact factor: 3.252

10.  On the origin of striatal cholecystokinin release: studies with in vivo microdialysis.

Authors:  Z B You; M Herrera-Marschitz; E Brodin; J J Meana; P Morino; T Hökfelt; R Silveira; M Goiny; U Ungerstedt
Journal:  J Neurochem       Date:  1994-01       Impact factor: 5.372

View more
  25 in total

1.  Requirement of phospholipase C and protein kinase C in cholecystokinin-mediated facilitation of NMDA channel function and anxiety-like behavior.

Authors:  Zhaoyang Xiao; Manoj K Jaiswal; Pan-Yue Deng; Toshimitsu Matsui; Hee-Sup Shin; James E Porter; Saobo Lei
Journal:  Hippocampus       Date:  2011-11-10       Impact factor: 3.899

2.  Phospholipase C not protein kinase C is required for the activation of TRPC5 channels by cholecystokinin.

Authors:  Laurel A Grisanti; Lalitha Kurada; Nicholas I Cilz; James E Porter; Saobo Lei
Journal:  Eur J Pharmacol       Date:  2012-06-07       Impact factor: 4.432

3.  Cholecystokinin facilitates neuronal excitability in the entorhinal cortex via activation of TRPC-like channels.

Authors:  Shouping Wang; An-Ping Zhang; Lalitha Kurada; Toshimitsu Matsui; Saobo Lei
Journal:  J Neurophysiol       Date:  2011-07-13       Impact factor: 2.714

4.  Modulation of GABAergic transmission by muscarinic receptors in the entorhinal cortex of juvenile rats.

Authors:  Zhaoyang Xiao; Pan-Yue Deng; Chuanxiu Yang; Saobo Lei
Journal:  J Neurophysiol       Date:  2009-06-03       Impact factor: 2.714

5.  Activation of group II metabotropic glutamate receptors inhibits glutamatergic transmission in the rat entorhinal cortex via reduction of glutamate release probability.

Authors:  Shouping Wang; Xiaotong Chen; Lalitha Kurada; Zitong Huang; Saobo Lei
Journal:  Cereb Cortex       Date:  2011-06-15       Impact factor: 5.357

6.  Neuropeptides Modulate Local Astrocytes to Regulate Adult Hippocampal Neural Stem Cells.

Authors:  Brent Asrican; Josh Wooten; Ya-Dong Li; Luis Quintanilla; Feiran Zhang; Connor Wander; Hechen Bao; Chia-Yu Yeh; Yan-Jia Luo; Reid Olsen; Szu-Aun Lim; Jessica Hu; Peng Jin; Juan Song
Journal:  Neuron       Date:  2020-09-01       Impact factor: 17.173

7.  Cholecystokinin selectively activates short axon cells to enhance inhibition of olfactory bulb output neurons.

Authors:  Xiang Liu; Shaolin Liu
Journal:  J Physiol       Date:  2018-04-16       Impact factor: 5.182

8.  Cholecystokinin facilitates glutamate release by increasing the number of readily releasable vesicles and releasing probability.

Authors:  Pan-Yue Deng; Zhaoyang Xiao; Archana Jha; David Ramonet; Toshimitsu Matsui; Michael Leitges; Hee-Sup Shin; James E Porter; Jonathan D Geiger; Saobo Lei
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

9.  Genetical genomic determinants of alcohol consumption in rats and humans.

Authors:  Boris Tabakoff; Laura Saba; Morton Printz; Pam Flodman; Colin Hodgkinson; David Goldman; George Koob; Heather N Richardson; Katerina Kechris; Richard L Bell; Norbert Hübner; Matthias Heinig; Michal Pravenec; Jonathan Mangion; Lucie Legault; Maurice Dongier; Katherine M Conigrave; John B Whitfield; John Saunders; Bridget Grant; Paula L Hoffman
Journal:  BMC Biol       Date:  2009-10-27       Impact factor: 7.431

10.  Vasopressin facilitates GABAergic transmission in rat hippocampus via activation of V(1A) receptors.

Authors:  Gunasekaran Ramanathan; Nicholas I Cilz; Lalitha Kurada; Binqi Hu; Xiaoping Wang; Saobo Lei
Journal:  Neuropharmacology       Date:  2012-08-03       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.